Elsevier

Biochemical Pharmacology

Volume 48, Issue 6, 15 September 1994, Pages 1187-1197
Biochemical Pharmacology

Phase I and phase II metabolism of lithocholic acid in hepatic acinar zone 3 necrosis: Evaluation in rats by combined radiochromatography and gas-liquid chromatograpry-mass spectrometry

https://doi.org/10.1016/0006-2952(94)90156-2Get rights and content

Abstract

In the present study, lithocholic acid (LCA) metabolism was assessed by radiochromatography and gas-liquid chromatography-mass spectrometry, and its relationship to cholestasis was investigated. In addition, the role of the perivenous zone in LCA-induced cholestasis and LCA biotransformation was examined by using bromobenzene (BZ), a chemical that causes selective necrosis of hepatocytes in this zone. LCA injection induced cholestasis of comparable amplitude in both control and BZ-treated rats. The biliary recovery of bile salts (BS) was 65–70% 2 hr after LCA injection. Excretion of LCA and its cholestatic metabolite, LCA glucuronide, was similar in both groups, although LCA excretion was delayed in BZ-treated animals. The appearance of LCA and LCA glucuronide in bile occurred early, and their proportion decreased with time. Concentrations of choleretic hydroxylated metabolites were low immediately after LCA injection but increased with time. 3α,6β-Dihydroxy-5β-cholanoic and 3α,6β,7β-trihydroxy-5β-cholanoic acids were the major species arising from LCA, indicating the importance of 6β hydroxylation in LCA detoxification in rats. Other metabolites were found, but their contribution was either minor or negligible. Overall amounts of hydroxylated metabolites were comparable in both groups, but trihydroxylated metabolites predominated over their dihydroxylated counterparts in control rats, whereas the production of dihydroxylated forms was more pronounced in BZ-treated animals. These results suggest that the destruction of perivenous hepatocytes does not exacerbate LCA-induced cholestasis, and that there may be an acinar zonation of LCA biotransformation to trihydroxylated metabolites in the rat liver.

References (51)

  • A Radomińska-Pyrek et al.

    Glucuronides of monohydroxylated bile acids: Specificity of microsomal glucuronyltransferase for the glucuronidation site, C-3 configuration, and side chain length

    J Lipid Res

    (1986)
  • IM Yousef et al.

    Superior gas-liquid chromatography of methyl cholanoate acetates on cyanopropylphenylsiloxane liquid phases

    Anal Biochem

    (1976)
  • KO Lindros et al.

    The γ-glutamyltransferase/glutamine synthetase activity ratio. A powerful marker for acinar origin of hepatocytes

    J Hepatol

    (1989)
  • KE Penttilä

    Allyl alcohol cytotoxicity and glutathione depletion

    Chem Biol Interact

    (1988)
  • P Zimniak et al.

    Detoxification of lithocholic acid. Elucidation of the pathways of oxidative metabolism in rat liver microsomes

    J Lipid Res

    (1989)
  • JM Little et al.

    Metabolism of lithocholic acid in rat: Formation of lithocholic acid 3-O-glucuronide in vivo

    J Lipid Res

    (1990)
  • PJ Thomas et al.

    Bile acids. XIX. Metabolism of lithocholic acid-24-14C in the rat

    J Biol Chem

    (1964)
  • NB Javitt

    Cholestasis induced in rats by taurolithocholate

    Nature

    (1966)
  • NB Javitt

    Effect of taurolithocholate on bile flow and bile acid excretion

    J Clin Invest

    (1968)
  • MM Fisher et al.

    Bile acid metabolism in mammals. 1. Bile acid-induced intrahepaticcholestasis

    Lab Invest

    (1971)
  • MJ Philips et al.

    The Steering Committee for the National Cooperative Gallstone Study Group, Ultrastructural evidence of intrahepatic cholestasis before and after chenodeoxycholic acid therapy in patients with cholelithiasis

    Hepatology

    (1983)
  • RL Fisher et al.

    A prospective morphologic evaluation of hepatic toxicity of chenodeoxycholic acid in patients with cholelithiasis

    Hepatology

    (1991)
  • DG Oelberg et al.

    Lithocholate glucuronide is a cholestatic agent

    J Clin Invest

    (1984)
  • U Baumgartner et al.

    Reduced cholestatic potency of taurolithocholate during backward perfusion of rat liver

    Lab Invest

    (1987)
  • K Jungermann et al.

    Functional specialization of different hepatocyte populations

    Physiol Rev

    (1989)
  • Cited by (22)

    • Application of gas chromatography-triple quadrupole mass spectrometry to the determination of sterol components in biological samples in consideration of the ionization mode

      2013, Biochimie
      Citation Excerpt :

      A crucial factor is derivatization. Some authors recommend the derivatization to methyl esters with subsequent trimethylsilylation [19,34,35] or methylation and acetylation [36,37]. We decided to convert the hydroxyl groups to trimethylsilylether groups expecting benefits for the MS precursor/product ion function as seen for the oxysterol species.

    • Isolation and chemical synthesis of a major, novel biliary bile acid in the common wombat (Vombatus ursinus): 15α-hydroxylithocholic acid

      2007, Journal of Lipid Research
      Citation Excerpt :

      If this hypothesis is correct, the wombat resembles other rodents [mouse (9–12, 32), rat (33–38), and guinea pig (39, 40)], species in which lithocholic acid is efficiently hydroxylated at C-6, C-7, or both during hepatocyte transport. Sulfation (36) and glucuronidation (35, 37) of lithocholic acid also occur in these species, but to a much smaller extent. N-Acylamidation (mostly with taurine) of the dihydroxy and trihydroxy metabolites of lithocholic acid occurs, but their sulfates and glucuronides have not been reported.

    • Preventive effect of silymarin against taurolithocholate-induced cholestasis in the rat

      2003, Biochemical Pharmacology
      Citation Excerpt :

      Biliary excretion of TMDC, which was also not detectable in basal conditions, reached a maximum at 40–60 min after TLC administration in TLC-treated rats, and SIL pretreatment was also able to accelerate its biliary output, particularly during the first collection periods (Fig. 4, lower panel); this led to a significant increment in the cumulative biliary output of TMDC of 70% (Fig. 4, lower panel, inset). Cumulative biliary output of taurine conjugates of CDC, β-MC and hyodeoxycholate, resulting from TLC phase I metabolism [32,33], as discriminated from changes in their excretions from endogenous sources using the non-TLC metabolite, cholate, as an internal standard [32], tended to be higher in SIL+TLC group than in rats only treated with TLC, but these results did not reach statistical significance (data not shown). The main finding of the present work is that the hepatoprotector SIL significantly prevents the acute cholestasis induced by a single, i.v. dose of TLC.

    View all citing articles on Scopus
    View full text